News
Novocure Announces Addition to Its Board of Directors
Novocure (NASDAQ: NVCR) has announced an addition to its board of directors. Timothy J. Scannell, an experienced executive leader, was elected to Novocure’s board on Feb. 5.
“We are extremely
ProvideGx® Partners with Apotex Corp. to Stabilize Supply of Three Vital Antibiotics
Premier Inc. (NASDAQ: PINC), through its ProvideGx® program, has partnered with Apotex Corp. to supply three essential antibiotics to healthcare providers, helping to secure the immediate and
Xencor to Present at Upcoming Investor Conferences
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced
Chemed To Report Fourth-Quarter 2020 Earnings February 23, Related Conference Call To Be Held On February 24
Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2020, on Tuesday, February 23, 2021, following the close of trading on
AMN Healthcare Achieves High Ranking in LGBTQ Corporate Equality Index
AMN Healthcare (NYSE: AMN) received a top ranking – 95 out of 100 – in the Human Rights Campaign Foundation’s 2021 Corporate Equality Index, the nation’s foremost survey measuring corporate
Premier, Inc. Reports Fiscal-Year 2021 Second-Quarter Results
Premier, Inc. (NASDAQ: PINC) today reported financial results for the fiscal year (FY) 2021 second quarter ended December 31, 2020 and announced its fiscal 2021 financial guidance.
All results
Premier Inc. President Michael J. Alkire to Succeed Susan DeVore as Chief Executive Officer
Premier Inc. (NASDAQ: PINC) today announced that after nearly 18 years of distinguished service, Susan DeVore is retiring as the company’s chief executive officer and a member of its Board of
Vifor Pharma to propose Dr Alexandre LeBeaut as Board member
Regulatory News:
Vifor Pharma today announced that the Board of Directors will propose Dr Alexandre LeBeaut for election to the Board at the next Annual General Meeting on 6 May 2021.
Jacques
AMN Healthcare Achieves Top Ranking Among Healthcare Companies in Bloomberg Gender-Equality Index
AMN Healthcare (NYSE: AMN) is one of 380 companies across 11 industry sectors and 44 countries included in the 2021 Bloomberg Gender-Equality Index (GEI). In the healthcare sector, AMN Healthcare
QIAGEN erweitert wachsendes Portfolio von COVID-19 Testlösungen um dPCR-Plattform QIAcuity für Abwasser- und Mutationstests
QIAGEN gab heute bekannt, dass das wachsende Portfolio an COVID-19-Produkten um Kits für Abwassertests ergänzt wird. Der Einsatz der Digitalen PCR (dPCR) bei der weltweiten Überwachung von COVID-19
QIAGEN Adds dPCR Platform QIAcuity to Growing Portfolio of COVID-19 Testing Solutions for Wastewater and Mutation Testing
QIAGEN today announced the addition of kits for wastewater testing to its growing portfolio of COVID-19 products. The use of dPCR in the worldwide surveillance of COVID-19 is an additional step
Charles River Announces Strategic Partnership with Cypre, Expanding 3D In Vitro Services for Cancer Immunotherapy and Targeted Therapy Drug Screening
Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a strategic partnership with Cypre, Inc., a biotechnology company that is using 3D hydrogel
QIAGEN N.V. to Report Fourth Quarter and Full-Year 2020 Results
QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced today that it plans to release its report on results for the fourth quarter and full-year 2020 on Tuesday, February 9,at
Premier, Inc. Declares Quarterly Cash Dividend
Premier, Inc. (NASDAQ: PINC), a leading healthcare improvement company, today announced that its Board of Directors declared a cash dividend of $0.19 per share of Class A common stock issued and
ProvideGx® Partners with Pfizer Inc. to Secure the Supply of Five Essential Medications
Premier Inc. (NASDAQ: PINC), through its ProvideGx® program, has partnered with Pfizer Inc. to supply five essential medications to healthcare providers, helping to meet the immediate and long-term
QIAGEN Confirms Effectiveness of Its SARS-CoV-2 PCR Tests in the Face of Mutations of the Coronavirus
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced its polymerase chain reaction (PCR) tests remain accurate and effective in detecting SARS-CoV-2 infections – and will
QIAGEN Plans to Resubmit EUA Submission in the U.S. for QIAreach SARS-CoV-2 Antigen Test in the First Quarter of 2021
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it plans to resubmit in the first quarter of 2021 its QIAreach SARS-CoV-2 Antigen Test to the U.S. Food and Drug
QIAGEN plant in den USA erneute Einreichung eines Antrags auf Notfallzulassung für den QIAreach SARS-CoV-2 Antigen Test im ersten Quartal 2021
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute Pläne bekannt, den QIAreach SARS-CoV-2 Antigen Test zum im ersten Quartal 2021 in den USA erneut zur Notfallzulassung (EUA) bei der
QIAGEN bestätigt Wirksamkeit seiner SARS-CoV-2 PCR-Tests angesichts neuer Mutationen des Coronavirus
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute bekannt, dass die Genauigkeit und Effektivität seiner Polymerase-Kettenreaktionstests (PCR) für den Nachweis von
LivaNova to Host Conference Call for Fourth Quarter and Full-Year 2020 Results
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its fourth quarter and full-year 2020 results on Wednesday, February
Charles River Laboratories Schedules Fourth-Quarter 2020 Earnings and 2021 Guidance Release and Conference Call
Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2020 financial results and provide 2021 guidance on Wednesday, February 17th, before the market
AMN Healthcare Ranked by Customers as a Leader in Total Workforce Solutions
AMN Healthcare’s commitment to developing comprehensive and integrated solutions to the challenges faced by healthcare organizations has resulted in a top-ten ranking among leaders in total
AMN Healthcare to Host Fourth Quarter and Full Year 2020 Earnings Conference Call on Thursday, February 18, 2021
AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations, has scheduled a conference call to discuss its fourth quarter and full
Genus plc Provides Update on Financial Performance for First Half of Fiscal 2021
Genus plc (LSE: GNS), a global biotechnology leader in animal genetics, today reported continued strong performance across its operations for the six-months period ending December 31, 2020.
The
Charles River Partners with JADE Biomedical to Expand Biologics Capabilities
Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a strategic partnership with JADE Biomedical (JADE), a provider of end-to-end quality management